Pfizer (PFE) on Saturday reported detailed results from several mid-stage trials, noting that its obesity therapy, berobenatide (PF3944), added from its Metsera acquisition last year, could become the first GLP-1 therapy approved for monthly dosing
Additionally, it improves overall performance and endurance in performance animals, helps in treating or preventing anemia due to Vitamin B12's role in red blood cell formation, and assists in faster recovery post-surgery by boosting metabolism and energy levels
Semaglutide solution should appear clear and colorless
Continued use maintains results, but consistency is essential
Available online: 39.Crespo J., Lpez-Arias M.J., Iruzubieta P